लोड हो रहा है...
Novel therapeutic options for second-line therapy in metastatic renal cell carcinoma
Metastatic renal cell carcinoma (mRCC) has gained a variety of therapeutic options since the introduction of targeted therapy, starting in 2007. The basic molecular mechanisms included predominantly the targeting of vascular endothelial growth factor or the inhibition of the mammalian target of rapa...
में बचाया:
| में प्रकाशित: | Mol Clin Oncol |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
D.A. Spandidos
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888023/ https://ncbi.nlm.nih.gov/pubmed/27313856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.856 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|